HealthDay News reports that in-utero exposure to paracetamol, a commonly used active ingredient for treatment, may be linked to differences in the reproductive system development of female infants. The finding was published on September 15, 2026, according to the provided report.
The research highlights potential developmental impacts associated with prenatal paracetamol exposure. While the medication is widely utilized during pregnancy, the observed reproductive differences in girls point to an area of ongoing health interest regarding maternal medication use.
In-depth summary · AI, neutral